RU2317293C9 - N-замещенные амиды индолил-3-глиоксиловой кислоты противоопухолевого действия, лекарственное средство на их основе, способ их получения и способ лечения опухолевых заболеваний - Google Patents

N-замещенные амиды индолил-3-глиоксиловой кислоты противоопухолевого действия, лекарственное средство на их основе, способ их получения и способ лечения опухолевых заболеваний Download PDF

Info

Publication number
RU2317293C9
RU2317293C9 RU2006105708/04A RU2006105708A RU2317293C9 RU 2317293 C9 RU2317293 C9 RU 2317293C9 RU 2006105708/04 A RU2006105708/04 A RU 2006105708/04A RU 2006105708 A RU2006105708 A RU 2006105708A RU 2317293 C9 RU2317293 C9 RU 2317293C9
Authority
RU
Russia
Prior art keywords
substituted
alkyl
indol
chlorobenzyl
quinolin
Prior art date
Application number
RU2006105708/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2317293C2 (ru
RU2006105708A (ru
Inventor
Сильке БААСНЕР (DE)
Сильке БААСНЕР
Матиас ГЕРЛАХ (DE)
Матиас ГЕРЛАХ
Экхард ГЮНТЕР (DE)
Экхард ГЮНТЕР
Петер ШМИДТ (DE)
Петер ШМИДТ
Тильман ШУСТЕР (DE)
Тильман ШУСТЕР
Original Assignee
Центарис Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центарис Гмбх filed Critical Центарис Гмбх
Publication of RU2006105708A publication Critical patent/RU2006105708A/ru
Publication of RU2317293C2 publication Critical patent/RU2317293C2/ru
Application granted granted Critical
Publication of RU2317293C9 publication Critical patent/RU2317293C9/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2006105708/04A 2003-07-25 2004-07-09 N-замещенные амиды индолил-3-глиоксиловой кислоты противоопухолевого действия, лекарственное средство на их основе, способ их получения и способ лечения опухолевых заболеваний RU2317293C9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10334040.8 2003-07-25
DE10334040A DE10334040A1 (de) 2003-07-25 2003-07-25 Neue N-substituierte Indolyl-3-glyoxylsäureamide, deren Verwendung als Arzneimittel und Verfahren zu deren Herstellung

Publications (3)

Publication Number Publication Date
RU2006105708A RU2006105708A (ru) 2006-06-27
RU2317293C2 RU2317293C2 (ru) 2008-02-20
RU2317293C9 true RU2317293C9 (ru) 2008-05-10

Family

ID=34129467

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006105708/04A RU2317293C9 (ru) 2003-07-25 2004-07-09 N-замещенные амиды индолил-3-глиоксиловой кислоты противоопухолевого действия, лекарственное средство на их основе, способ их получения и способ лечения опухолевых заболеваний

Country Status (18)

Country Link
EP (1) EP1651600A2 (de)
JP (1) JP2007503376A (de)
KR (1) KR20060037398A (de)
CN (1) CN1839129A (de)
AR (1) AR045928A1 (de)
AU (1) AU2004263238A1 (de)
BR (1) BRPI0412898A (de)
CA (1) CA2533433A1 (de)
DE (1) DE10334040A1 (de)
IL (1) IL173335A0 (de)
MX (1) MXPA06000995A (de)
NO (1) NO20060697L (de)
RS (1) RS20060049A (de)
RU (1) RU2317293C9 (de)
TW (1) TW200524863A (de)
UA (1) UA83498C2 (de)
WO (1) WO2005014542A2 (de)
ZA (1) ZA200601300B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008019357A2 (en) 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2460347A1 (en) * 2001-09-13 2003-03-20 Synta Pharmaceuticals Corp. 3-glyoxlylamideindoles for treating cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Li WT et al., Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents. Journal of Medicinal Chemistry, 2003, 46(9), p.1706-15. *

Also Published As

Publication number Publication date
TW200524863A (en) 2005-08-01
JP2007503376A (ja) 2007-02-22
IL173335A0 (en) 2006-06-11
WO2005014542A2 (de) 2005-02-17
EP1651600A2 (de) 2006-05-03
DE10334040A1 (de) 2005-03-10
WO2005014542A3 (de) 2006-10-19
MXPA06000995A (es) 2006-04-11
RU2317293C2 (ru) 2008-02-20
KR20060037398A (ko) 2006-05-03
CA2533433A1 (en) 2005-02-17
RS20060049A (en) 2008-08-07
BRPI0412898A (pt) 2006-10-03
CN1839129A (zh) 2006-09-27
AU2004263238A1 (en) 2005-02-17
ZA200601300B (en) 2007-03-28
NO20060697L (no) 2006-02-14
UA83498C2 (uk) 2008-07-25
AR045928A1 (es) 2005-11-16
RU2006105708A (ru) 2006-06-27

Similar Documents

Publication Publication Date Title
ES2374449T3 (es) Compuestos de imidazol sustituidos como inhibidores de ksp.
ES2945573T3 (es) Compuesto de dioxazolina, método de preparación y usos del mismo
HRP20050092A2 (en) Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
US9242966B2 (en) Phthalazines as potassium ion channel inhibitors
ES2450067T3 (es) Derivados de pirido[2,3-d]pirimidina, proceso para su preparación y su uso terapéutico
WO2013007184A1 (zh) 抗肿瘤药物四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用
JP2515434B2 (ja) 2−アミノピリミジン−4−カルボキサミド誘導体、その製造法およびそれを含有する医薬
JP5583201B2 (ja) キノキサリン誘導体並びに良性の及び悪性の腫瘍疾患の治療のためのその使用
CN110229171B (zh) 一种噁嗪并喹唑啉与噁嗪并喹啉类化合物及其制备方法和应用
RU2317293C9 (ru) N-замещенные амиды индолил-3-глиоксиловой кислоты противоопухолевого действия, лекарственное средство на их основе, способ их получения и способ лечения опухолевых заболеваний
US7211588B2 (en) N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
CN110229172B (zh) 一种酰基取代的噁嗪并喹唑啉类化合物、制备方法及其应用
CN109476605B (zh) 具有抗肿瘤活性的苯并-n-羟基酰胺化合物
CN108948003B (zh) 作为mTOR抑制剂的吡嗪并[2,3-c]喹啉-2(1H)-酮类化合物的制备及用途
CN111253325A (zh) 氨基喹唑啉芳基哌嗪类化合物及其药物组合物和应用
CN116529252A (zh) 用于持续释放治疗剂的前药及其用途

Legal Events

Date Code Title Description
TH4A Reissue of patent specification
MM4A The patent is invalid due to non-payment of fees

Effective date: 20100710